Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uropathogenic Escherichia coli | 2 | 2020 | 5 | 1.300 |
Why?
|
| Estrogen Receptor beta | 2 | 2020 | 13 | 1.290 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 26 | 1.280 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 39 | 1.260 |
Why?
|
| Urinary Bladder | 2 | 2020 | 118 | 0.800 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 130 | 0.800 |
Why?
|
| Liver Neoplasms | 2 | 2017 | 164 | 0.770 |
Why?
|
| Nanodiamonds | 2 | 2018 | 2 | 0.720 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 159 | 0.630 |
Why?
|
| Epithelial Cells | 1 | 2020 | 241 | 0.620 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 30 | 0.560 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 43 | 0.480 |
Why?
|
| NF-kappa B | 2 | 2017 | 188 | 0.460 |
Why?
|
| Liver | 2 | 2017 | 424 | 0.410 |
Why?
|
| Bacteria, Aerobic | 1 | 2010 | 4 | 0.360 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 22 | 0.350 |
Why?
|
| Liver Diseases | 1 | 2010 | 51 | 0.340 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 73 | 0.310 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 25 | 0.310 |
Why?
|
| Estrogens | 2 | 2020 | 56 | 0.250 |
Why?
|
| I-kappa B Kinase | 2 | 2017 | 8 | 0.230 |
Why?
|
| Phosphorylation | 2 | 2017 | 568 | 0.210 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2020 | 1 | 0.180 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2018 | 31 | 0.180 |
Why?
|
| Menopause | 1 | 2020 | 28 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 76 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 195 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 129 | 0.160 |
Why?
|
| Hepacivirus | 2 | 2017 | 47 | 0.160 |
Why?
|
| Female | 4 | 2020 | 14661 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2020 | 214 | 0.150 |
Why?
|
| Humans | 6 | 2020 | 27160 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2020 | 978 | 0.150 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 81 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 80 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2017 | 57 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 110 | 0.140 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 240 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 2017 | 38 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2020 | 775 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2017 | 135 | 0.140 |
Why?
|
| Pregnancy | 1 | 2020 | 1154 | 0.130 |
Why?
|
| Amoxicillin | 1 | 2016 | 6 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 452 | 0.130 |
Why?
|
| Cell Line | 1 | 2018 | 683 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2016 | 110 | 0.120 |
Why?
|
| Middle Aged | 2 | 2017 | 6913 | 0.100 |
Why?
|
| Male | 3 | 2017 | 13040 | 0.100 |
Why?
|
| Animals | 2 | 2020 | 10093 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 498 | 0.090 |
Why?
|
| Mice | 1 | 2020 | 4478 | 0.090 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2010 | 10 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 33 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 30 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 71 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 55 | 0.080 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 67 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 408 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 47 | 0.080 |
Why?
|
| Aged | 1 | 2017 | 5231 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2008 | 163 | 0.070 |
Why?
|
| Hepatitis B | 1 | 2007 | 12 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2007 | 61 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2007 | 40 | 0.070 |
Why?
|
| Adult | 1 | 2017 | 7506 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 1406 | 0.050 |
Why?
|
| Drug Liberation | 1 | 2016 | 24 | 0.030 |
Why?
|
| Static Electricity | 1 | 2016 | 34 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 35 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 73 | 0.030 |
Why?
|
| Polyethyleneimine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 96 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 132 | 0.030 |
Why?
|
| Viral Vaccines | 1 | 2007 | 12 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2007 | 16 | 0.020 |
Why?
|
| Global Health | 1 | 2007 | 43 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 345 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2007 | 111 | 0.020 |
Why?
|